Regimens for Drug-Resistant Tuberculosis
N Engl J Med
.
2023 Jan 12;388(2):189.
doi: 10.1056/NEJMc2213970.
Authors
Rubeshan Perumal
1
,
Camus Nimmo
2
,
Max O'Donnell
3
Affiliations
1
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
2
Francis Crick Institute, London, United Kingdom.
3
Columbia University Irving Medical Center, New York, NY.
PMID:
36630636
DOI:
10.1056/NEJMc2213970
No abstract available
Publication types
Letter
Comment
MeSH terms
Diarylquinolines
Humans
Linezolid
Tuberculosis, Multidrug-Resistant* / drug therapy
Substances
bedaquiline
Linezolid
pretomanid
Diarylquinolines